Ionis Pharmaceuticals

Crossing crosswalk walking road
Biotech

Ionis rare disease candidate ekes out phase 3 win

Out of 54 patients with Alexander disease, those given zilganersen could walk an average of 33.3% faster in a 10-meter walk test at 61 weeks.
Darren Incorvaia Sep 22, 2025 10:46am
patent infringement patent lawsuit

Arrowhead sues Ionis over patent dispute for Tryngolza rival

Sep 11, 2025 11:33am
RNA Concept 3D Render

RNA biotech emerges with $52M and clinical rare disease asset

Aug 25, 2025 10:13am
An artists 3D rendering of cancerous blood cells among healthy red blood cells The cells fill the image and are of various

Ono pays $280M upfront for Ionis' phase 2 blood cancer med

Mar 12, 2025 6:30am
photo of a royal flush laid out on the poker table with chips scattered nearby

Arrowhead posts phase 3 data ahead of market clash with Ionis

Sep 3, 2024 9:27am
fence palisade wall defense fence gate fortress fort

Arrowhead RNAi med lowers triglycerides in phase 3

Jun 3, 2024 9:54am